Mink Therapeutics Inc (INKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,807 | 9,526 | 13,360 | 14,281 | 1,682 |
| Other current assets | 212 | 232 | 211 | 0 | 55 |
| TOTAL | $9,297 | $10,023 | $13,848 | $14,534 | $2,011 |
| Non-Current Assets | |||||
| PPE Net | 319 | 355 | 391 | 429 | 473 |
| TOTAL | $319 | $355 | $391 | $429 | $473 |
| Total Assets | $9,615 | $10,377 | $14,239 | $14,964 | $2,484 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,919 | 3,391 | 3,425 | 3,693 | 3,315 |
| Accrued Expenses | 1,196 | 1,326 | 1,579 | 1,257 | 1,862 |
| Other current liabilities | 2,454 | 2,570 | 2,848 | 2,758 | 2,481 |
| TOTAL | $7,569 | $7,287 | $13,032 | $13,434 | $13,164 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 16,075 | 15,776 | 15,435 | 15,043 | 14,510 |
| TOTAL | $16,075 | $15,776 | $15,435 | $15,043 | $14,510 |
| Total Liabilities | $23,644 | $23,063 | $28,467 | $28,477 | $27,674 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,103 | 4,982 | 4,966 | 4,694 | 4,523 |
| Retained earnings | -162,547 | -159,418 | -156,676 | -154,074 | -151,186 |
| Other shareholders' equity | -700 | -697 | -719 | -692 | -719 |
| TOTAL | $-14,028 | $-12,686 | $-14,228 | $-13,513 | $-25,189 |
| Total Liabilities And Equity | $9,615 | $10,377 | $14,239 | $14,964 | $2,484 |